GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » PuriBlood Medical Co Ltd (ROCO:6847) » Definitions » Total Liabilities

PuriBlood Medical Co (ROCO:6847) Total Liabilities : NT$72.3 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is PuriBlood Medical Co Total Liabilities?

PuriBlood Medical Co's Total Liabilities for the quarter that ended in Jun. 2024 was NT$72.3 Mil.

PuriBlood Medical Co's quarterly Total Liabilities declined from Jun. 2023 (NT$88.85 Mil) to Dec. 2023 (NT$84.35 Mil) and declined from Dec. 2023 (NT$84.35 Mil) to Jun. 2024 (NT$72.26 Mil).

PuriBlood Medical Co's annual Total Liabilities increased from Dec. 2021 (NT$49.11 Mil) to Dec. 2022 (NT$87.47 Mil) but then declined from Dec. 2022 (NT$87.47 Mil) to Dec. 2023 (NT$84.35 Mil).


PuriBlood Medical Co Total Liabilities Historical Data

The historical data trend for PuriBlood Medical Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PuriBlood Medical Co Total Liabilities Chart

PuriBlood Medical Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial 58.85 51.94 49.11 87.47 84.35

PuriBlood Medical Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 90.22 87.47 88.85 84.35 72.26

PuriBlood Medical Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

PuriBlood Medical Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=39.893+(43.701+0.00099999999999789
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.756+0)
=84.4

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=265.512-181.161
=84.4

PuriBlood Medical Co's Total Liabilities for the quarter that ended in Jun. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=31.296+(39.74+0.356
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0.868+0)
=72.3

Total Liabilities=Total Assets (Q: Jun. 2024 )-Total Equity (Q: Jun. 2024 )
=241.002-168.742
=72.3

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


PuriBlood Medical Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of PuriBlood Medical Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


PuriBlood Medical Co Business Description

Traded in Other Exchanges
N/A
Address
Gongye E. 9th Road, Baoshan Township, 2nd Floor, No.11, Hsinchu County, Baoshan, TWN
PuriBlood Medical Co Ltd is engaged in developing solutions for leukoreduction, cell separation, and anti-fouling materials. Its technology protects to supports living beings from medical devices to daily protection. The products of the company include Leukoreduction, Cell Separation, and P-tex.

PuriBlood Medical Co Headlines

No Headlines